Coronavirus update: Regeneron, Eli Lilly seek FDA approval of antibodies, boosted by Trump's bout with COVID

The president has created a conundrum by pushing for emergency use authorization (EUA) in a way that suggests the process could be politically influenced. …read more

Source:: Yahoo Finance

Discover Tomorrow’s Winning Stocks!
Get our latest stock reports before everyone else! Actionable news, and breakout stocks w multi-bagger upside potential — delivered directly to your inbox.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.